{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:01:27Z","timestamp":1793703687199,"version":"4.5.1"},"reference-count":88,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Critical Path for Parkinson's members"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Transformation in the neurosciences in biomarkers is enabling novel therapeutic strategies targeting earlier stages of disease prior to onset of clinical symptoms. Emerging progress in the area of synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB) have significant implications for clinical trials. Misfolded \u03b1-synuclein aggregates (syn-seeds) propagate by templated misfolding of native \u03b1-synuclein, driving disease spread. The advent of the \u03b1-synuclein seed amplification assay (syn SAA) now enables highly sensitive and specific detection of syn-seeds in cerebrospinal fluid (CSF), allowing in vivo identification of underlying \u03b1-synuclein pathology, including in individuals prior to the onset of motor symptoms.<\/jats:p>\n                  <jats:p>To support regulatory alignment, the Critical Path Institute's Critical Path for Parkinson's (CPP) consortium compiled and evaluated the totality of scientific evidence in the area of syn SAA as an in vivo measure of misfolded alpha synuclein in CSF and submitted it to the U.S. Food and Drug Administration (FDA) in a request for a Biomarker Letter of Support (LoS). Within three months of submission, the FDA issued a LoS endorsing CSF syn SAA as a susceptibility and risk biomarker for use in clinical trials targeting \u03b1-synuclein\u2013related neurodegenerative diseases, enabling enrichment of participants with underlying pathology and reducing trial risk. These data have enabled the development of biological classification frameworks for synucleinopathies that define disease based on molecular pathology rather than clinical symptoms alone.<\/jats:p>\n                  <jats:p>This review summarizes the regulatory-grade evidence supporting syn SAA and discusses its implications for biologically driven clinical trial design and early-intervention strategies.<\/jats:p>","DOI":"10.1177\/1877718x261463936","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:51:13Z","timestamp":1784883073000},"page":"1296-1312","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulatory endorsement for the application of \u03b1-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-436X","authenticated-orcid":false,"given":"Diane","family":"Stephenson","sequence":"first","affiliation":[{"name":"Neuroscience Department, Critical Path Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-8389","authenticated-orcid":false,"given":"Luis","family":"Concha-Marambio","sequence":"additional","affiliation":[{"name":"Amprion Inc., San Diego, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-3122","authenticated-orcid":false,"given":"Tom","family":"Lanz","sequence":"additional","affiliation":[{"name":"Pfizer Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Merchant","sequence":"additional","affiliation":[{"name":"Northwestern Univ, TransThera Consulting Co"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Brockmann","sequence":"additional","affiliation":[{"name":", University of T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0063-2617","authenticated-orcid":false,"given":"Nicholas","family":"King","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Critical Path Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7359-4670","authenticated-orcid":false,"given":"Laura","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Critical Path Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pedata","sequence":"additional","affiliation":[{"name":"Neuroscience Department, Critical Path Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Kocherla","sequence":"additional","affiliation":[{"name":"Novartis AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8435-744X","authenticated-orcid":false,"given":"Samantha J","family":"Hutten","sequence":"additional","affiliation":[{"name":"The Michael J. Fox Foundation for Parkinson's Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Critical Path for Parkinson's Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00633-2"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.136"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-020-00255-8"},{"key":"e_1_3_4_5_2","first-page":"1877718X2614319","article-title":"Collaborative action for biomarker breakthroughs: validating \u03b1-synuclein seed amplification assays in Parkinson\u2019s disease","author":"Oliveira LM","year":"2026","unstructured":"Oliveira LM, Frasier M, Hutten SJ. Collaborative action for biomarker breakthroughs: validating \u03b1-synuclein seed amplification assays in Parkinson\u2019s disease. J Parkinson\u2019s Dis 2026: 1877718X261431949.","journal-title":"J Parkinson\u2019s Dis"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160573"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.15109"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010346"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12619"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-191648"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-023-01440-x"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-021-00275-y"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70966"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00156"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008870"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000314478"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29590"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27485"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00030-2"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316844"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22826"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001807"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-012-0577-4"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26000"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.08.016"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.02.023"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00595"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.487"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6469"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1227157"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2045"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00405-2"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00404-0"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/35081095"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6801762"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1066"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0308-211"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2294"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404401"},{"key":"e_1_3_4_41_2","first-page":"35","volume-title":"Alpha-Synuclein: methods and protocols","author":"Concha-Marambio L","unstructured":"Concha-Marambio L, Shahnawaz M, Soto C. Detection of misfolded \u03b1-synuclein aggregates in cerebrospinal fluid by the protein misfolding cyclic amplification platform. In: Bartels T (eds) Alpha-Synuclein: methods and protocols. Springer, pp.35\u201344."},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.02.031"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1692-z"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.338"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4547"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01388-7"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00395-8"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02160-8"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13799"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00109-6"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14276"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26453"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03469-7"},{"key":"e_1_3_4_54_2","first-page":"370","article-title":"Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease","volume":"8","author":"Concha-Marambio L","unstructured":"Concha-Marambio L, Pritzkow S, Moda F, et al. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 21 Dec 2016; 8: 370\u2013383.","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28715"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11810-2"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70165"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105807"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27646"},{"key":"e_1_3_4_60_2","first-page":"1","article-title":"High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease","volume":"9","author":"Russo MJ","year":"2021","unstructured":"Russo MJ, Orru CD, Concha-Marambio L, et al. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. acta Neuropathol Commun 2021; 9: 1\u201313.","journal-title":"acta Neuropathol Commun"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70017"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-022-00787-3"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30449-X"},{"key":"e_1_3_4_64_2","unstructured":"Marek K. The Parkinson\u2019s Progression Markers Initiative (PPMI). Clinical Trial Registration NCT01141023 clinicaltrials.gov https:\/\/clinicaltrials.gov\/study\/NCT01141023 (13 November 2023 accessed 31 December 2023)."},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02449-7"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02450-0"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.0985"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105567"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27158"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01276-6"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00627-5"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203395"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00789-w"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202867"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.2217\/pme-2016-0052"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05190-y"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00473-5"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214648"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-026-01282-2"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217750088"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells15050451"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00157-7"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200878"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70384"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214614"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-025-02872-9"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00120-X"},{"key":"e_1_3_4_88_2","article-title":"Application of the revised criteria for diagnosis and staging of Alzheimer\u2019s disease: drug development and clinical practice","volume":"10","author":"Jack CR","year":"2024","unstructured":"Jack CR, Graf A, Burnham SC, et al. Application of the revised criteria for diagnosis and staging of Alzheimer\u2019s disease: drug development and clinical practice. Alzheimer\u2019s Dementia 2024; 10: e70013.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200789"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261463936","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261463936","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261463936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:14:20Z","timestamp":1789136060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261463936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/1877718X261463936"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261463936","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}